AMNEAL PHARMACEUTICALS, INC. Finance Lease, Liability, Undiscounted Excess Amount
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Finance Lease, Liability, Undiscounted Excess Amount of $41.46 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-27
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $41.46M.
- 2024-12-31: Finance Lease, Liability, Undiscounted Excess Amount $45.53M.
- 2023-12-31: Finance Lease, Liability, Undiscounted Excess Amount $49.70M.
- 2022-12-31: Finance Lease, Liability, Undiscounted Excess Amount $53.95M.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount | Finance Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2025-12-31 | $41.46M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $45.53M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $49.70M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $53.95M 10-K · filed 2024-03-14 | |
| 2021-12-31 | $57.25M 10-K · filed 2023-03-03 | |
| 2020-12-31 | $61.64M 10-K · filed 2022-03-01 | $61.35M 10-K · filed 2021-03-01 |
| 2019-12-31 | $66.12M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $67.23M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $68.35M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $69.47M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |